Membranous glomerulopathy: The evolving story

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 3, 2010, Pages 254-259

  Ronco, Pierre ^a,b,c   Debiec, Hanna ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL TENON   (France)

Author keywords

Complement; Megalin; Membranous nephropathy; Neutral endopeptidase; PLA 2R; Podocyte

Indexed keywords

AUTOANTIGEN; MEGALIN; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHOLIPASE A2 RECEPTOR; TUMSTATIN;

ADULT; DISEASE ACTIVITY; DRUG TARGETING; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOLOGICAL TOLERANCE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AUTOANTIGENS; ENDOPEPTIDASES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; RECEPTORS, PHOSPHOLIPASE A2;

EID: 77951485167     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328336eafd     Document Type: Review

References (44)

1. Wasserstein AG. Membranous glomerulonephritis. J Am Soc Nephrol 1997; 8:664-674.
2. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23:324-332.
3. Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 2002; 41:936-942. (Pubitemid 35423073)
4. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-NEP antibodies. N Engl J Med 2002; 346:2053-2060.
5. Debiec H, NautaJ,Coulet F, etal. Role of truncating mutations in MMEgene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet 2004; 364:1252-1259. (Pubitemid 39311346)
6. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 1982; 79:5557-5561. (Pubitemid 13197683)
7. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 157:667-686. (Pubitemid 13145068)
8. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic MN. N Engl J Med 2009; 361:11-21.
9. Heymann W, Hackel DB, Harwood S, etal. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspension. Proc Soc Exp Biol Med 1959; 100:660-664.
10. Van Damme BJ, Fleuren GJ, Bakker WW, et al. Experimental glomerulo-nephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 1978; 38:502-510. (Pubitemid 8338244)
11. Couser WG, Steinmuller DR, Stilmant MM, et al. Experimental glomerulo-nephritisinthe isolated perfused rat kidney.J Clin Invest 1978; 62:1275-1287. (Pubitemid 9075757)
12. Saito A, Pietromonaco S, Loo AKC, Farquhar MG. Complete cloning and sequencing of rat gp330/'megalin,' a distinctive member of the low density lipoprotein receptor family. Proc Natl Acad Sci USA 1994; 91:9725-9729. (Pubitemid 24311880)
13. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 2002; 3:256-266. (Pubitemid 34619261)
14. Tramontano A, Knight T, Vizzuso D, Makker SP. Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis. J Am Soc Nephrol 2006; 17:1979-1985. (Pubitemid 44036182)
15. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephro-pathy: from Heyman's nephritis to allo-immunization. J Am Soc Nephrol 2005; 16:1205-1213. (Pubitemid 41716505)
16. Hörl WH, Kerjaschki D. Membranous glomerulonephritis (MGN). J Nephrol 2000; 13:291-316. (Pubitemid 30618073)
17. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity (clinical conference). Kidney Int 1999; 56:355-377.
18. Chen JS, Chen A, Chang LC, et al. Mouse model of MN induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant 2004; 19:2721-2728. (Pubitemid 39480964)
19. Hunley TE, Corzo D, Dudek M, et al. Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease. Pediatrics 2004; 114:532-535. (Pubitemid 41529751)
20. Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease: characterization of a single conformational epitope as the target of pathogenic auto-antibodies. J Biol Chem 1999; 274:25862-25868. (Pubitemid 129530766)
21. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol 2004; 15:2514-2527.
22. Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008; 14:1088-1096.
23. Shah P, Tramontano A, Makker SP. Intramolecular epitope spreading in Heymann nephritis. J Am Soc Nephrol 2007; 18:3060-3066. (Pubitemid 350223966)
24. Lundberg K, Venables PJ. Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis. Arthritis Res Ther 2008; 10:122.
25. Chen L, Hellmark T, Pedchenko V, et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2006; 17:3076-3081. (Pubitemid 44707768)
26. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002; 105:9-19. (Pubitemid 34128035)
27. Zanetti M, Druet P. Passive Heymann's nephritis as a model of immuneglomer-ulonephritis mediated by antibodies to immunoglobulins. Clin Exp Immunol 1980; 41:189-195. (Pubitemid 10043036)
28. Hennig C, Rink L, Kirchner H. Evidence for presence of IgG4 antiimmunoglobulin autoantibodies in all human beings. Lancet 2000; 355:1617-1618. (Pubitemid 30240512)
29. Spicer ST, Tran GT, Killingsworth MC, et al. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J Immunol 2007; 179:172-178.
30. Kerjaschki D, Exner M, Ullrich R, et al. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 1997; 100:2303-2309.
31. Turner AJ, Isaac RE, Coates D. The neprilysin (NEP) family of zinc metallo-endopeptidases: genomics and function. Bioessays 2001; 23:261-269.
32. Sumimoto M, Shen R, Nanus DM. Involvement of neutral endopeptidase in neoplastic progression. Biochim Biophys Acta 2005; 1751:52-59.
33. Terawaki SI, Kitano K, Hakoshima T. Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24-11 (NEP) complex. J Biol Chem 2007; 282:19854-19862.
34. East L, Isacke CM. The mannose receptor family. Biochim Biophys Acta 2002; 1572:364-386.
35. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998; 163:19-34.
36. Hanasaki K. Mammalian phospholipase A2: phospholipase A2 receptor. Biol Pharm Bull 2004; 27:1165-1167.
37. Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 2008; 77:495-520.
38. 2R regulates senescence through the p53 pathway. EMBO Rep 2009; 10:271-277.
39. Binstadt BA, Patel PR, Alencar H, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006; 7:284-292.
40. Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007; 7:665-677.
41. Reynolds J, Prodromidi EI, Juggapah JK, et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 2005; 16:1350-1359.
42. Reynolds J, Abbott DS, Karegli J, et al. Mucosal tolerance induced by an immunodominant peptide from ratalpha3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol 2009; 174:2202-2210.
43. Debiec H, Ronco P. Fetomaternal alloimmunization with antenatal glomerulopathies. Ann N Y Acad Sci 2007; 1110:559-566.
44. Nortier JL, Debiec H,Tournay Y, et al. Neonatal disease in NEP alloimmunization: lessons for pregnancy management and immunological monitoring. Pediatr Nephrol 2006; 21:1399-1405.